The two Brians - one the actor, the other the scientist - described a mishap they were involved in when they tried to check into the same hotel. A member of staff said: 'I know neither of you, I don't watch television.'
"And he said, 'no, no, there's only one, but I think there might be another Brian Cox' and the hotel said to Brian, 'we can't have two Brian Coxes'."The Succession star continued:"They wouldn't check him in, so he had to use his assistant's name."
Professor Brian Cox said:"I had to change my name. They couldn't do it on their computer system. They didn't believe me! "And I got a picture up on my phone and said 'Look, this is Brian Cox, he'll be coming later, and then this one…' and he said, 'I know neither of you, I don't watch television'."Thespian Brian Cox previously revealed he was initially"irked" by his namesake after the pair were nearly mixed up on a restaurant reservation.
When both Brians sat down with The Guardian earlier this year, the Shakespearean actor said:"It annoyed me initially - but has been such a great lesson - to find someone who is extraordinarily successful with the same name as me.
Österreich Neuesten Nachrichten, Österreich Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Succession's Brian Cox and Professor Brian Cox finally meet on BBC BreakfastThe actor Brian Cox and the professor Brian Cox have finally been united in the same room, on the same show and even on the same sofa for BBC Breakfast. It's a moment! 🤩
Weiterlesen »
Brian Cox And Brian Cox Share Hilarious Hotel Mix-Up Story As They Come Face To Face On BBC Breakfast“Last night was very confusing when he arrived to the hotel.'
Weiterlesen »
Coinbase’s Brian Armstrong: ‘I’m just as bullish on crypto as ever’\n\t\t\tExpert insights, analysis and smart data help you cut through the noise to spot trends,\n\t\t\trisks and opportunities.\n\t\t\n\t\tJoin over 300,000 Finance professionals who already subscribe to the FT.
Weiterlesen »
NI man on discovering he had large aneurysm after having no symptomsBrian discovered he had a Abdominal Aortic Aneurysm (AAA) which required surgery
Weiterlesen »
Proguanil and atovaquone use is associated with lower colorectal cancer risk: a nationwide cohort study - BMC MedicineBackground Individuals with a family history of colorectal cancer (CRC) are at a high risk of developing CRC. Preclinical studies suggest that the anti-malaria drug proguanil and atovaquone might play a role in preventing CRC, but population-based evidence is still lacking. Methods By accessing a couple of nationwide Swedish registers, we performed a cohort study to explore whether using proguanil and atovaquone might associate with a lower risk of CRC by adopting a new-user study design. Adults who have 1 or more first-degree relatives (parents or siblings) diagnosed with CRC were identified and linked with the Prescribed Drug Register to evaluate their administration history of proguanil and atovaquone. Survival analysis of the time to CRC diagnosis with Cox proportional hazards regression was used to estimate hazard ratios (HRs) and 95% confidence intervals (CIs). Results A total of 16,817 incident proguanil/atovaquone users were identified and matched with 168,170 comparisons, who did not use proguanil/atovaquone, on the ratio of 1:10. We found a significant negative association between proguanil/atovaquone use and risk of CRC (adjusted HR, 0.76; 95% CI, 0.62–0.93). Test for trend showed significant dose- and duration-response correlations (P | 0.001). The association was more pronounced in CRC diagnosed at an advanced stage than at an early stage (adjusted HR, 0.69 vs.0.81). Conclusions This national-wide population-based cohort study showed that the use of proguanil and atovaquone was associated with a reduced risk of CRC among individuals with a family history of CRC.
Weiterlesen »